ArticleJournal of molecular histology2026
Development of metabolic syndrome by increasingly fructose-enriched water in Wistar rats.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several studies have shown that excessive fructose consumption increases the risk of developing metabolic syndrome (MS), which can lead to diabetes mellitus. This study aimed to evaluate the metabolic and histological abnormalities accompanying MS induced by progressive high fructose diet (HFr) in Wistar rats. Twelve Wistar rats were used, divided into two groups (n = 6) (NC and HFr). They were fed a HFr with daily administration of increasingly higher doses of fructose solutions (dose 1 = 20% from week 1 to 4, dose 2 = 25% from week 5 to 8 and dose 3 = 30% from week 9 to 12 ), during which body weight and blood glucose were measured, while an oral glucose tolerance test (OGTT) was performed, it's glucose, triglyceride, and total cholesterol concentrations were determined, and pancreatic, liver, and kidney tissues were studied at the end of the experiment. Daily administration of increasingly high doses of fructose caused body weight increase, manifested by a highly significant difference in body weight, a metabolic abnormality, differences in fasting blood glucose (hyperglycaemia), plasma concentration of glucose, glucose intolerance, and by a very significant increase of total cholesterol and triglycerides levels in blood (hyperlipidaemia) between HFr and NC groups of rats. Histopathological study showed a slight swelling of the hepatocytes and a narrowing of the blood sinusoids, as well as an inflammatory infiltration of the portal space in the hepatic section of HFr group, no morphological alterations, necrosis, or steatosis in the pancreatic and renal sections of HFr group of rats. A twelve-week HFr diet can cause some abnormalities in the liver tissue, in carbohydrate and lipid metabolism in Wistar rats without damaging their pancreas and kidneys, which may be explained by the fact that metabolic abnormalities can precede histological lesions.
Indexed as
Identifiers
41872523What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.